LIVIVO - The Search Portal for Life Sciences

zur deutschen Oberfläche wechseln
Advanced search

Search results

Result 1 - 8 of total 8

Search options

  1. Article ; Online: High altitude is associated with pTau deposition, neuroinflammation, and myelin loss.

    Iacono, Diego / Murphy, Erin K / Sherman, Paul M / Chapapas, Holly / Cerqueira, Bianca / Christensen, Christine / Perl, Daniel P / Sladky, John

    Scientific reports

    2022  Volume 12, Issue 1, Page(s) 6839

    Abstract: Mammals are able to adapt to high altitude (HA) if appropriate acclimation occurs. However, specific occupations (professional climbers, pilots, astronauts and other) can be exposed to HA without acclimation and be at a higher risk of brain consequences. ...

    Abstract Mammals are able to adapt to high altitude (HA) if appropriate acclimation occurs. However, specific occupations (professional climbers, pilots, astronauts and other) can be exposed to HA without acclimation and be at a higher risk of brain consequences. In particular, US Air Force U2-pilots have been shown to develop white matter hyperintensities (WMH) on MRI. Whether WMH are due to hypoxia or hypobaria effects is not understood. We compared swine brains exposed to 5000 feet (1524 m) above sea level (SL) with 21% fraction inspired O
    MeSH term(s) Altitude ; Animals ; Brain/diagnostic imaging ; Brain/pathology ; Magnetic Resonance Imaging ; Mammals ; Myelin Sheath ; Neuroinflammatory Diseases ; Swine
    Language English
    Publishing date 2022-04-27
    Publishing country England
    Document type Journal Article ; Research Support, U.S. Gov't, Non-P.H.S.
    ZDB-ID 2615211-3
    ISSN 2045-2322 ; 2045-2322
    ISSN (online) 2045-2322
    ISSN 2045-2322
    DOI 10.1038/s41598-022-10881-x
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  2. Article ; Online: Chronic oral methylene blue treatment in a rat model of focal cerebral ischemia/reperfusion.

    Huang, Lei / Lu, Jianfei / Cerqueira, Bianca / Liu, Yichu / Jiang, Zhao / Duong, Timothy Q

    Brain research

    2018  Volume 1678, Page(s) 322–329

    Abstract: A single acute low-dose methylene blue (MB), an FDA-grandfathered drug, has been shown to ameliorate behavioral deficits and reduces MRI-defined infarct volume in experimental ischemic stroke when administered intravenously or intraperitoneally. The ... ...

    Abstract A single acute low-dose methylene blue (MB), an FDA-grandfathered drug, has been shown to ameliorate behavioral deficits and reduces MRI-defined infarct volume in experimental ischemic stroke when administered intravenously or intraperitoneally. The efficacy of chronic MB treatment in ischemic stroke remains unknown. In a randomized, double-blinded and vehicle-controlled design, we investigated the efficacy of chronic oral MB administration in ischemic stroke longitudinally up to 60 days post injury using MRI and behavioral tests, with end-point histology. The major findings were chronic oral MB treatment, compared to vehicle, i) improves functional behavioral outcomes starting on day 7 and up to 60 days, ii) reduces MRI-defined total lesion volumes from day 14 and up to 60 days where some initial abnormal MRI-defined core and perfusion-diffusion mismatch were salvaged, iii) reduces white-matter damage, iv) gray matter and white matter damages are consistent with Nissl stains and Black Gold stain histology. These findings provide further evidence that long-term oral administration of low-dose MB is safe and has positive therapeutic effects in chronic ischemic stroke.
    MeSH term(s) Administration, Oral ; Analysis of Variance ; Animals ; Disease Models, Animal ; Double-Blind Method ; Image Processing, Computer-Assisted ; Infarction, Middle Cerebral Artery/diagnostic imaging ; Infarction, Middle Cerebral Artery/drug therapy ; Infarction, Middle Cerebral Artery/physiopathology ; Magnetic Resonance Imaging ; Male ; Methylene Blue/administration & dosage ; Neuroprotective Agents/administration & dosage ; Rats ; Rats, Sprague-Dawley ; Reperfusion ; Sensory Gating/drug effects ; Sensory Gating/physiology ; Silver Staining ; Spin Labels
    Chemical Substances Neuroprotective Agents ; Spin Labels ; Methylene Blue (T42P99266K)
    Language English
    Publishing date 2018-01-01
    Publishing country Netherlands
    Document type Journal Article ; Randomized Controlled Trial
    ZDB-ID 1200-2
    ISSN 1872-6240 ; 0006-8993
    ISSN (online) 1872-6240
    ISSN 0006-8993
    DOI 10.1016/j.brainres.2017.10.033
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  3. Article ; Online: Intraarterial transplantation of human umbilical cord blood mononuclear cells in hyperacute stroke improves vascular function.

    Huang, Lei / Liu, Yichu / Lu, Jianfei / Cerqueira, Bianca / Misra, Vivek / Duong, Timothy Q

    Stem cell research & therapy

    2017  Volume 8, Issue 1, Page(s) 74

    Abstract: Background: Human umbilical cord blood (hUCB) cell therapy is a promising treatment for ischemic stroke. The effects of hyperacute stem cell transplantation on cerebrovascular function in ischemic stroke are, however, not well understood. This study ... ...

    Abstract Background: Human umbilical cord blood (hUCB) cell therapy is a promising treatment for ischemic stroke. The effects of hyperacute stem cell transplantation on cerebrovascular function in ischemic stroke are, however, not well understood. This study evaluated the effects of hyperacute intraarterial transplantation of hUCB mononuclear cells (MNCs) on cerebrovascular function in stroke rats using serial magnetic resonance imaging (MRI).
    Methods: HUCB MNCs or vehicle were administered to stroke rats via the internal carotid artery immediately after reperfusion at 60 min following ischemia onset. Lesion volumes were longitudinally evaluated by MRI on days 0, 2, 14, and 28 after stroke, accompanied by behavioral tests. Cerebral blood flow (CBF) and cerebrovascular reactivity were measured by perfusion MRI and CO
    Results: We found that CBF to the stroke-affected region at 28 days was improved (normalized CBF value: 1.41 ± 0.30 versus 0.49 ± 0.07) by intraarterial transplantation of hUCB MNCs in the hyperacute stroke phase, compared to vehicle control. Cerebrovascular reactivity within the stroke-affected area, measured by CBF fMRI, was also increased (35.2 ± 3.5% versus 12.8 ± 4.3%), as well as the corresponding cerebrovascular density. Some engrafted cells appeared with microvascular-like morphology and stained positive for von Willebrand Factor (an endothelial cell marker), suggesting they differentiated into endothelial cells. Some engrafted cells also connected to host endothelial cells, suggesting they interacted with the host vasculature. Compared to the vehicle group, infarct volume at 28 days in the stem cell treated group was significantly smaller (160.9 ± 15.7 versus 231.2 ± 16.0 mm
    Conclusions: Intraarterial hUCB MNC transplantation during the hyperacute phase of ischemic stroke improved cerebrovascular function and reduced behavioral deficits and infarct volume.
    MeSH term(s) Animals ; Biomarkers/metabolism ; Blood Flow Velocity ; Brain Ischemia/metabolism ; Brain Ischemia/pathology ; Brain Ischemia/therapy ; Carotid Artery, Internal ; Cell Differentiation ; Cell Separation ; Cerebrovascular Circulation ; Disease Models, Animal ; Endothelial Cells/cytology ; Endothelial Cells/metabolism ; Fetal Blood/cytology ; Fetal Blood/metabolism ; Gene Expression ; Humans ; Injections, Intra-Arterial ; Leukocytes, Mononuclear/cytology ; Leukocytes, Mononuclear/metabolism ; Leukocytes, Mononuclear/transplantation ; Male ; Postural Balance/physiology ; Rats ; Rats, Sprague-Dawley ; Stroke/metabolism ; Stroke/pathology ; Stroke/therapy ; Transplantation, Heterologous ; von Willebrand Factor/genetics ; von Willebrand Factor/metabolism
    Chemical Substances Biomarkers ; von Willebrand Factor
    Language English
    Publishing date 2017-03-22
    Publishing country England
    Document type Journal Article
    ZDB-ID 2548671-8
    ISSN 1757-6512 ; 1757-6512
    ISSN (online) 1757-6512
    ISSN 1757-6512
    DOI 10.1186/s13287-017-0529-y
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  4. Article ; Online: Magnetic resonance imaging of blood-brain barrier permeability in ischemic stroke using diffusion-weighted arterial spin labeling in rats.

    Tiwari, Yash V / Lu, Jianfei / Shen, Qiang / Cerqueira, Bianca / Duong, Timothy Q

    Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism

    2016  Volume 37, Issue 8, Page(s) 2706–2715

    Abstract: Diffusion-weighted arterial spin labeling magnetic resonance imaging has recently been proposed to quantify the rate of water exchange ( ... ...

    Abstract Diffusion-weighted arterial spin labeling magnetic resonance imaging has recently been proposed to quantify the rate of water exchange (K
    MeSH term(s) Animals ; Blood-Brain Barrier/diagnostic imaging ; Blood-Brain Barrier/physiopathology ; Capillary Permeability/physiology ; Contrast Media ; Diffusion Magnetic Resonance Imaging/methods ; Disease Models, Animal ; Evans Blue ; Ischemic Attack, Transient/diagnostic imaging ; Ischemic Attack, Transient/physiopathology ; Male ; Perfusion ; Rats, Sprague-Dawley ; Spin Labels
    Chemical Substances Contrast Media ; Spin Labels ; Evans Blue (45PG892GO1)
    Language English
    Publishing date 2016-01-01
    Publishing country United States
    Document type Journal Article
    ZDB-ID 604628-9
    ISSN 1559-7016 ; 0271-678X
    ISSN (online) 1559-7016
    ISSN 0271-678X
    DOI 10.1177/0271678X16673385
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  5. McDonald, J Tyson / Enguita, Francisco Javier / Taylor, Deanne / Griffin, Robert J / Priebe, Waldemar / Emmett, Mark R / Sajadi, Mohammad M / Harris, Anthony D / Clement, Jean / Dybas, Joseph M / Aykin-Burns, Nukhet / Guarnieri, Joseph W / Singh, Larry N / Grabham, Peter / Baylin, Stephen B / Yousey, Aliza / Pearson, Andrea N / Corry, Peter M / Saravia-Butler, Amanda /
    Aunins, Thomas R / Sharma, Sadhana / Nagpal, Prashant / Meydan, Cem / Foox, Jonathan / Mozsary, Christopher / Cerqueira, Bianca / Zaksas, Viktorija / Singh, Urminder / Wurtele, Eve Syrkin / Costes, Sylvain V / Davanzo, Gustavo Gastão / Galeano, Diego / Paccanaro, Alberto / Meinig, Suzanne L / Hagan, Robert S / Bowman, Natalie M / Wolfgang, Matthew C / Altinok, Selin / Sapoval, Nicolae / Treangen, Todd J / Moraes-Vieira, Pedro M / Vanderburg, Charles / Wallace, Douglas C / Schisler, Jonathan / Mason, Christopher E / Chatterjee, Anushree / Meller, Robert / Beheshti, Afshin

    bioRxiv : the preprint server for biology

    2021  

    Abstract: MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provides an exciting avenue towards antiviral therapeutics. From patient transcriptomic data, we have discovered a ...

    Abstract MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provides an exciting avenue towards antiviral therapeutics. From patient transcriptomic data, we have discovered a circulating miRNA, miR-2392, that is directly involved with SARS-CoV-2 machinery during host infection. Specifically, we show that miR-2392 is key in driving downstream suppression of mitochondrial gene expression, increasing inflammation, glycolysis, and hypoxia as well as promoting many symptoms associated with COVID-19 infection. We demonstrate miR-2392 is present in the blood and urine of COVID-19 positive patients, but not detected in COVID-19 negative patients. These findings indicate the potential for developing a novel, minimally invasive, COVID-19 detection method. Lastly, using
    Language English
    Publishing date 2021-08-18
    Publishing country United States
    Document type Preprint
    DOI 10.1101/2021.04.23.441024
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  6. Article ; Online: Role of miR-2392 in driving SARS-CoV-2 infection.

    McDonald, J Tyson / Enguita, Francisco J / Taylor, Deanne / Griffin, Robert J / Priebe, Waldemar / Emmett, Mark R / Sajadi, Mohammad M / Harris, Anthony D / Clement, Jean / Dybas, Joseph M / Aykin-Burns, Nukhet / Guarnieri, Joseph W / Singh, Larry N / Grabham, Peter / Baylin, Stephen B / Yousey, Aliza / Pearson, Andrea N / Corry, Peter M / Saravia-Butler, Amanda /
    Aunins, Thomas R / Sharma, Sadhana / Nagpal, Prashant / Meydan, Cem / Foox, Jonathan / Mozsary, Christopher / Cerqueira, Bianca / Zaksas, Viktorija / Singh, Urminder / Wurtele, Eve Syrkin / Costes, Sylvain V / Davanzo, Gustavo Gastão / Galeano, Diego / Paccanaro, Alberto / Meinig, Suzanne L / Hagan, Robert S / Bowman, Natalie M / Wolfgang, Matthew C / Altinok, Selin / Sapoval, Nicolae / Treangen, Todd J / Moraes-Vieira, Pedro M / Vanderburg, Charles / Wallace, Douglas C / Schisler, Jonathan C / Mason, Christopher E / Chatterjee, Anushree / Meller, Robert / Beheshti, Afshin

    Cell reports

    2021  Volume 37, Issue 3, Page(s) 109839

    Abstract: MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provide an exciting avenue toward antiviral therapeutics. From patient transcriptomic data, we determined that a ... ...

    Abstract MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provide an exciting avenue toward antiviral therapeutics. From patient transcriptomic data, we determined that a circulating miRNA, miR-2392, is directly involved with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) machinery during host infection. Specifically, we show that miR-2392 is key in driving downstream suppression of mitochondrial gene expression, increasing inflammation, glycolysis, and hypoxia, as well as promoting many symptoms associated with coronavirus disease 2019 (COVID-19) infection. We demonstrate that miR-2392 is present in the blood and urine of patients positive for COVID-19 but is not present in patients negative for COVID-19. These findings indicate the potential for developing a minimally invasive COVID-19 detection method. Lastly, using in vitro human and in vivo hamster models, we design a miRNA-based antiviral therapeutic that targets miR-2392, significantly reduces SARS-CoV-2 viability in hamsters, and may potentially inhibit a COVID-19 disease state in humans.
    MeSH term(s) Adult ; Aged ; Aged, 80 and over ; Animals ; Antiviral Agents/pharmacology ; Biomarkers/metabolism ; COVID-19/genetics ; COVID-19/immunology ; Cricetinae ; Female ; Ferrets ; Gene Expression Regulation ; Glycolysis ; Healthy Volunteers ; Humans ; Hypoxia ; Inflammation ; Male ; Mice ; MicroRNAs/genetics ; Middle Aged ; Proteomics/methods ; ROC Curve ; Rats ; SARS-CoV-2/genetics ; COVID-19 Drug Treatment
    Chemical Substances Antiviral Agents ; Biomarkers ; MIRN2392 microRNA, human ; MicroRNAs
    Language English
    Publishing date 2021-09-30
    Publishing country United States
    Document type Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't ; Research Support, U.S. Gov't, P.H.S.
    ZDB-ID 2649101-1
    ISSN 2211-1247 ; 2211-1247
    ISSN (online) 2211-1247
    ISSN 2211-1247
    DOI 10.1016/j.celrep.2021.109839
    Database MEDical Literature Analysis and Retrieval System OnLINE

    More links

    Kategorien

  7. McDonald, J. Tyson / Enguita, Francisco Javier / Taylor, Deanne / Bowen, Richard A / Griffin, Robert J / Priebe, Waldemar / Emmett, Mark R / McGrath, Marisa / Sajadi, Mohammad / Harris, Anthony D / Clement, Jean / Dybas, Joseph M / Aykin-Burns, Nukhet / Guarnieri, Joseph W / Singh, Larry N / Grabham, Peter / Baylin, Stephen / Yousey, Aliza / Pearson, Andrea N /
    Corry, Peter M / Saravia-Butler, Amanda / Aunins, Thomas R / Nagpal, Prashant / Meydan, Cem / Foox, Jonathan / Mozsary, Christopher / Cerqueira, Bianca / Zaksas, Viktorija / Singh, Urminder / Wurtele, Eve Syrkin / Costes, Sylvain V / Galeano, Diego / Paccanaro, Alberto / Meinig, Suzanne L / Hagan, Robert S / Bowman, Natalie M / UNC COVID-19 Pathobiology Consortium / Wolfgang, Matthew C / Altinok, Selin / Sapoval, Nicolae / Treangen, Todd J / Frieman, Matthew / Vanderburg, Charles / Schisler, Jonathan C / Mason, Christopher / Chatterjee, Anushree / Meller, Robert / Beheshti, Afshin

    bioRxiv

    Abstract: MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provides an exciting avenue towards antiviral therapeutics. From patient transcriptomic data, we have discovered a ...

    Abstract MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provides an exciting avenue towards antiviral therapeutics. From patient transcriptomic data, we have discovered a circulating miRNA, miR-2392, that is directly involved with SARS-CoV-2 machinery during host infection. Specifically, we found that miR-2392 was key in driving downstream suppression of mitochondrial gene expression, increasing inflammation, glycolysis, and hypoxia as well as promoting many symptoms associated with COVID-19 infection. We demonstrate miR-2392 is present in the blood and urine of COVID-19 patients tested, but not detected in COVID-19 negative patients. These findings indicate the potential for developing a novel, minimally invasive, COVID-19 detection method. Lastly, using both in vitro human and in vivo hamster models, we have developed a novel miRNA-based antiviral therapeutic targeting miR-2392 that significantly reduces SARS-CoV-2 viability and may potentially inhibit a COVID-19 disease state in the host.
    Keywords covid19
    Language English
    Publishing date 2021-04-23
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2021.04.23.441024
    Database COVID19

    Kategorien

  8. Article ; Online: The Great Deceiver: miR-2392’s Hidden Role in Driving SARS-CoV-2 Infection

    McDonald, J. Tyson / Enguita, Francisco Javier / Taylor, Deanne / Bowen, Richard A. / Griffin, Robert J. / Priebe, Waldemar / Emmett, Mark R. / McGrath, Marisa / Sajadi, Mohammad M. / Harris, Anthony D. / Clement, Jean / Dybas, Joseph M. / Aykin-Burns, Nukhet / Guarnieri, Joseph W. / Singh, Larry N. / Grabham, Peter / Baylin, Stephen B. / Yousey, Aliza / Pearson, Andrea N. /
    Corry, Peter M. / Saravia-Butler, Amanda / Aunins, Thomas R. / Nagpal, Prashant / Meydan, Cem / Foox, Jonathan / Mozsary, Christopher / Cerqueira, Bianca / Zaksas, Viktorija / Singh, Urminder / Wurtele, Eve Syrkin / Costes, Sylvain V. / Galeano, Diego / Paccanaro, Alberto / Meinig, Suzanne L. / Hagan, Robert S. / Bowman, Natalie M / UNC COVID-19 Pathobiology Consortium / Wolfgang, Matthew C. / Altinok, Selin / Sapoval, Nicolae / Treangen, Todd J. / Frieman, Matthew / Vanderburg, Charles / Wallace, Douglas C. / Schisler, Jonathan / Mason, Christopher E. / Chatterjee, Anushree / Meller, Robert / Beheshti, Afshin

    bioRxiv

    Abstract: MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provides an exciting avenue towards antiviral therapeutics. From patient transcriptomic data, we have discovered a ...

    Abstract MicroRNAs (miRNAs) are small non-coding RNAs involved in post-transcriptional gene regulation that have a major impact on many diseases and provides an exciting avenue towards antiviral therapeutics. From patient transcriptomic data, we have discovered a circulating miRNA, miR-2392, that is directly involved with SARS-CoV-2 machinery during host infection. Specifically, we found that miR-2392 was key in driving downstream suppression of mitochondrial gene expression, increasing inflammation, glycolysis, and hypoxia as well as promoting many symptoms associated with COVID-19 infection. We demonstrate miR-2392 is present in the blood and urine of COVID-19 patients tested, but not detected in COVID-19 negative patients. These findings indicate the potential for developing a novel, minimally invasive, COVID-19 detection method. Lastly, using both in vitro human and in vivo hamster models, we have developed a novel miRNA-based antiviral therapeutic targeting miR-2392 that significantly reduces SARS-CoV-2 viability and may potentially inhibit a COVID-19 disease state in the host.
    Keywords covid19
    Language English
    Publishing date 2021-04-23
    Publisher Cold Spring Harbor Laboratory
    Document type Article ; Online
    DOI 10.1101/2021.04.23.441024
    Database COVID19

    Kategorien

To top